BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7920436)

  • 21. Pharmacokinetics and metabolism of pirarubicin in humans: correlation with pharmacodynamics.
    Marchiset-Leca D; Leca FR; Galeani A; Noble A; Catalin J
    Cancer Chemother Pharmacol; 1995; 36(3):239-43. PubMed ID: 7781145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possibility of contribution of nucleoside transport systems to pirarubicin uptake by HL60 cells but not mononuclear cells.
    Nagasawa K; Ohnishi N; Yokoyama T
    Jpn J Cancer Res; 1998 Jun; 89(6):673-80. PubMed ID: 9703366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of anthracyclines on phospholipase A2 activity and prostaglandin E2 production in rat gastric mucosa.
    Grataroli R; Leonardi J; Chautan M; Lafont H; Nalbone G
    Biochem Pharmacol; 1993 Aug; 46(3):349-55. PubMed ID: 8347160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uptake of L-tri-iodothyronine by isolated rat liver cells. A process partially inhibited by metabolic inhibitors; attempts to distinguish between uptake and binding to intracellular proteins.
    Eckel J; Rao GS; Rao ML; Breuer H
    Biochem J; 1979 Aug; 182(2):473-91. PubMed ID: 41520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
    Mankhetkorn S; Garnier-Suillerot A
    Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics of new anthracyclines].
    Robert J
    Bull Cancer; 1988; 75(2):167-74. PubMed ID: 3282579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Permeability of lipid bilayer to anthracycline derivatives. Role of the bilayer composition and of the temperature.
    Frézard F; Garnier-Suillerot A
    Biochim Biophys Acta; 1998 Jan; 1389(1):13-22. PubMed ID: 9443599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of metabolic inhibitors and incubation temperature on the saturable uptake of propranolol by isolated rat lung tissue.
    Iwamoto K; Watanabe J; Yonekawa H
    J Pharm Pharmacol; 1989 Aug; 41(8):572-4. PubMed ID: 2571706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vivo and in-vitro evidence of a carrier-mediated efflux transport system for oestrone-3-sulphate across the blood-cerebrospinal fluid barrier.
    Kitazawa T; Hosoya K; Takahashi T; Sugiyama Y; Terasaki T
    J Pharm Pharmacol; 2000 Mar; 52(3):281-8. PubMed ID: 10757415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accumulation and activity of cethromycin (ABT-773) within human polymorphonuclear leucocytes.
    García I; Pascual A; Ballesta S; del Castillo C; Perea EJ
    J Antimicrob Chemother; 2003 Jul; 52(1):24-8. PubMed ID: 12805263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quinine uptake by human polymorphonuclear neutrophils.
    el Benna J; Pasquier C; Labro MT
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1474-8. PubMed ID: 1929310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin.
    Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J
    Cancer Chemother Pharmacol; 1995; 35(3):257-61. PubMed ID: 7805186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A limited sampling strategy for the study of pirarubicin pharmacokinetics in humans.
    Marchiset-Leca D; Leca FR; Galeani A; Noble A; Iliadis A
    Cancer Chemother Pharmacol; 1995; 36(3):233-8. PubMed ID: 7781144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of 4'-0-tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinoma.
    Sridhar KS; Hussein AM; Benedetto P; Ardalan B; Savaraj N; Richman SP
    Cancer; 1992 Sep; 70(6):1591-7. PubMed ID: 1516010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of triiodothyronine transport and accumulation in rat erythrocytes.
    Osty J; Jego L; Francon J; Blondeau JP
    Endocrinology; 1988 Nov; 123(5):2303-11. PubMed ID: 3168926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of pirarubicin in plasma and cerebrospinal fluid.
    Morikawa N; Takeyama M; Mori T; Hori S
    Ann Pharmacother; 1998 Feb; 32(2):269. PubMed ID: 9496418
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of metabolic inhibition and changes of intracellular pH on potassium permeability and contraction of rat uterus.
    Heaton RC; Wray S; Eisner DA
    J Physiol; 1993 Jun; 465():43-56. PubMed ID: 8229844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clindamycin uptake by human neutrophils.
    Klempner MS; Styrt B
    J Infect Dis; 1981 Nov; 144(5):472-9. PubMed ID: 6171600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uptake of doxorubicin by cultured kidney epithelial cells LLC-PK1.
    Sasaya M; Wada I; Shida M; Sato M; Hatakeyama Y; Saitoh H; Takada M
    Biol Pharm Bull; 1998 May; 21(5):527-9. PubMed ID: 9635513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.